study comparing margetuximab combinations to trastuzumab combinations in her2-positive breast cancer
Published 3 years ago • 399 plays • Length 3:51Download video MP4
Download video MP3
Similar videos
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
4:31
study of atezolizumab with pertuzumab and trastuzumab in her2- positive metastatic breast cancer
-
3:19
study of targeted therapy for her2-positive metastatic breast cancer
-
4:14
study of gdc-0084 with trastuzumab in her2-positive breast cancer with brain metastases
-
49:09
metastatic breast cancer forum 2018: her2-positive breast cancer | dana-farber cancer institute
-
2:25
what is her2-positive breast cancer? | dana-farber cancer institute
-
53:19
her2 positive breast cancer: what's new in treatment and research at mbc patient forum 2019
-
0:59
treatment for early stage her2 breast cancer | dana-farber cancer institute
-
3:08
study shows new drug combination may benefit women with er/pr-positive breast cancer
-
1:23
ont-380 in combination with capecitabine and trastuzumab in her2-positive breast cancer
-
17:01
breast cancer genomics and precision cancer medicine | dana-farber cancer institute
-
1:35
advances in novel adcs for her2-expressing breast cancer
-
26:31
targeting advanced triple-negative breast cancer | dana-farber cancer institute
-
2:43
margetuximab for the treatment of her2-positive breast cancer
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
1:36
is her2-low a distinct subtype of breast cancer?
-
2:25
optimizing therapy for her2-positive breast cancer study (compassher2-pcr)
-
2:43
study of ds-8201a in her2-low, unresectable and/or metastatic breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases